care planning Archives - NCCS - National Coalition for Cancer Survivorship

Posts

NCCS Survivorship Survey: Cancer Survivors Share Their Top Concerns

September 15, 2019/in Cancer News, Cancer Policy Blog, NCCS News Access to Care, Care Planning, Financial Toxicity, Health Care Coverage, Health Equity, Quality Cancer Care, Survivorship Care NCCS News /by actualize

As part of its Elevating Survivorship initiative, the National Coalition for Cancer Survivorship (NCCS) fielded an online survey to understand cancer survivorship experiences and needs across a range of cancer patients.

NCCS and our partner patient advocacy organizations promoted the survey to our constituents, and 1,380 cancer survivors responded.

Some of the key findings include:

Treatment Experiences

Patients report many physical and emotional side effects (See Figure 1). Fatigue and anxiety top the list of both the most common and long-term effects. These are also among the most severe side effects reported by patients.
However, patients report that while healthcare providers are helpful at addressing their physical side effects such as nausea and vomiting, health care providers (HCPs) are far less helpful at addressing fatigue, anxiety, depression and cognitive effects.

I do wish that my health care team did more to address the emotional side effects, particularly in screening for it. I developed a lot of anxiety, but I just thought it was normal. Only in retrospect did I realize I had a problem.Survey Respondent

Post-Treatment Information and Care

Few feel very prepared for the transition to post-treatment, nor informed about how to manage their health post-treatment.
While most patients have spoken to a healthcare provider about post-treatment care, over half say they asked their doctor/HCP, and far fewer say their provider initiated these conversations.
Satisfaction with post-treatment care is varied, with few describing it as excellent. As a result, more rely on online sources for information rather than their HCPs.

I wish that my health care team would address survivorship issues and long-term effects of my cancer diagnosis. At this point I am just told to call if there are any changes in the way that I feel, this leaves me feeling uneasy and uncertain about the future of my health.Survey Respondent

Survivorship Needs

Figure 2. Click to expand.

When asked to identify their level of concern about a range of issues, financial issues tops the list (getting/keeping health insurance, having financial support), followed by managing ongoing side effects, uncertainty about the future, and having the energy to make it through the day.
There is clearly a disconnect between patient concerns and support from HCPs. Less than a third rate their HCP as “very helpful” on their top issues.
Many are interested in survivorship resources, especially programs for managing long-term symptoms, but few say these are available from the HCPs today (See Figure 2).

I would like to meet more cancer survivors. I feel now that I am a different person and that no one understands what I’ve been through. Most people think that because you survived, that you are great and not in need anymore. It would be helpful to have some friends who have gone through the same journey.Survey Respondent

ACCC and NCCS Joint Survey Report

The Association for Community Cancer Centers (ACCC) conducted a companion survey of its provider members, and the results of the two surveys were published in ACCC’s Oncology Issues journal:

Read “Elevating Survivorship: Results from Two National Surveys” [PDF] »

Read the Final Survey Report

NCCS thanks the following organizations for promoting the survey to its stakeholders: CancerCare, Fight Colorectal Cancer, Melanoma Research Alliance, Ovarian Cancer Research Alliance, the LIVESTRONG Foundation, Melanoma Research Foundation, Supporting Our Sisters Inc., Cancer Support Community, and LUNGevity.

Read the full final report of the Survivorship Survey below or download it here (PDF Document).

Grant funding for Elevating Survivorship provided by: Bristol-Myers Squibb, AbbVie, Pharmacyclics, Takeda, Celgene, Novartis, and Eisai.

Health Care Roundup: Cancer Care Planning Bill Introduced; Drug Pricing Measures Advance; Rural Hospitals Struggling in States that Did Not Expand Medicaid; More

August 2, 2019/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Care Planning, Drug Pricing, Financial Toxicity, Health Care Coverage, Health Equity, Quality Cancer Care Health Care Roundup, NCCS News /by actualize

We aim to make the Health Care Roundup a concise, one-stop summary of what you need to know as we continue working together to make cancer care better for everyone.Your feedback is always welcome to make our content more useful to you. Please send comments to feedback@canceradvocacy.org.

Subscribe to our email list and receive these updates in your email box each week »

HEALTH CARE HIGHLIGHTS

Cancer Care Planning and Communications Act Introduced in the House

On July 23, the Cancer Care Planning and Communications Act (CCPCA), H.R. 3835, was reintroduced in the House of Representatives. The bill is sponsored by Rep. Mark DeSaulnier (D-CA) and Rep. Buddy Carter (R-GA), co-chairs of the Congressional Cancer Survivors Caucus. The CCPCA is NCCS’ top legislative priority as it would increase access to comprehensive cancer care planning for millions of Medicare beneficiaries. If implemented in Medicare, it is our hope that private insurers would adopt similar measures.

You can find more information about the CCPCA here. NCCS also recently hosted a webinar and created a toolkit about how to meet with your Members of Congress during the August recess and advocate for the CCPCA and other cancer care issues. Check out the webinar and toolkit »

Drug Importation Plan Announced

The Department of Health and Human Services (HHS) announced Wednesday an action plan for the “safe importation” of drugs. The plan has two parts. First, HHS would undertake a rulemaking process to establish a system for states and other entities to engage in drug importation from Canada. The second part of the effort would be to establish a pathway at the Food and Drug Administration (FDA) for manufacturers to import versions of drugs that they currently sell in foreign countries. Although many in the cancer community believe importation would not have a major impact on cancer drug access or pricing, the Trump Administration specifically mentions “cancer” in the second part of the plan.

To be clear, this is only the first step in a lengthy process, and NCCS will continue to monitor and report on any further developments.

Read the HHS press release announcing the plan »
For additional analysis, read this article from STAT News »

Senate Drug Pricing Package

Last week, the Senate Finance Committee approved a drug pricing bill by a vote of 19 to 9. However, the bill continues to face several serious challenges according to several reports. Republican Senators expressed concerns about the bill. The pharmaceutical industry lobbied aggressively against it on Capitol Hill this week. Democrats pledged that they would agree to floor action on the bill only if there is a vote on protecting pre-existing conditions and a vote on allowing Medicare to negotiate drug prices during consideration of the bill.

Needless to say, the bill’s fate is far from certain. Here is a Washington Post article with additional background and a Kaiser Health News report that focuses on the political challenges facing the package.

CHART OF THE WEEK

Rural hospitals foundering in states that declined Obamacare

GateHouse News

To be fair, the challenges rural hospitals and providers face began well before the passage of the Affordable Care Act (ACA). But as this map and the associated research shows, refusing the ACA hasn’t helped matters.

“The irony to me,” said John Henderson, who heads The Texas Organization of Rural & Community Hospitals and supports Medicaid expansion, “is that we’re paying federal income taxes to expand coverage in other states. We’re exporting our coverage and leaving billions of dollars on the table.”

Support NCCS while shopping on Amazon. A portion of your Amazon purchases will be donated to NCCS when you choose NCCS as your AmazonSmile charity. Get started »

IMPORTANT READS

Trump Administration Moves to Make Health Care Costs More Transparent

Kaiser Health News

Earlier this week, the Trump administration released a proposed new rule “that would provide consumers far more detail about the actual prices hospitals charge insurers.” There is ongoing debate regarding to what degree patients “shop around” for health care as consumers do for other goods and services. That said, more transparency to give patients—as well as employers and insurers for that matter—more information regarding costs could be a welcome step forward.

The new bipartisan Senate bill aimed at making Big Pharma lower drug prices, explained

Vox.com

This article looks at another drug pricing bill in the Senate, sponsored by Sens. Chris Van Hollen (D-MD) and Rick Scott (R-FL). As Vox.com explains it:

“Their new bill would require companies that have received research funding from the National Institutes of Health and other federal agencies to follow specific pricing restrictions for the drugs they are selling. If they don’t, they’d incur strict penalties.”

The bill only applies to new drugs, and not those currently on the market. With so much focus on this issue in Congress, it will be interesting to see if these and other drug pricing bills gain traction and get voted on.

Finding My Greater Purpose Through Patient Advocacy

CURE Magazine

The author shares her personal experience with cancer and how her journey motivates her, even more than thirty years later, to be a patient advocate.

Study: the US could have averted about 15,600 deaths if every state expanded Medicaid

Vox.com

We often highlight how critically important the Affordable Care Act (ACA) is to cancer patients and their families. This article discusses a recent study that shows the ACA’s impact on mortality more generally, saying:

“[The researchers] found that by the fourth year of Medicaid expansion, mortality rates in states that expanded the program were 0.2 percentage points lower than in states that did not.”

Health Care Roundup: ACA Lawsuit Update; Chronic Pain Study; “Have Cancer, Must Travel;” “Survivorship Issues Reshape a Researcher’s Career;” More

Health Care Roundup: Medicaid Work Requirement Studies; Care Coordination/Planning; Financial & Emotional Distress; Cancer in Firefighters; More

NCCS Applauds Introduction by Reps. DeSaulnier and Carter of Bipartisan “Cancer Care Planning and Communications Act”

July 23, 2019/in Cancer News, Cancer Policy Blog, NCCS News Access to Care, Care Planning, Health Care Coverage, Quality Cancer Care NCCS News /by actualize

Championed by NCCS, the bill would increase comprehensive cancer care planning for millions of Medicare beneficiaries.

Washington, D.C. – Today, Rep. Mark DeSaulnier (D-CA) and Rep. Buddy Carter (R-GA), co-chairs of the Congressional Cancer Survivors Caucus, introduced H.R. 3835, the Cancer Care Planning and Communications Act (CCPCA). A legislative priority of the National Coalition for Cancer Survivorship (NCCS), the bill would create a Medicare service to reimburse providers for time and resources used to create cancer care plans for Medicare beneficiaries.

“The Cancer Care Planning and Communications Act is a bipartisan effort that would significantly improve the quality of cancer care patients receive in Medicare,” said NCCS CEO Shelley Fuld Nasso. “Care planning, including the provider-patient discussions about cancer care, would go a long way to alleviating some of the anxiety patients experience before, during, and after treatment. The CCPCA would help both providers and patients with the tools and resources to manage and coordinate their care from active treatment throughout survivorship. NCCS commends Reps. DeSaulnier and Carter for their leadership in fighting for cancer patients and survivors, and we look forward to working with them to pass the CCPCA.”

“Medical breakthroughs are at an all-time high, but advancements in doctor-patient communications are not keeping pace. We know that less than half of all cancer patients feel adequately informed about their diagnosis. Without a written plan explaining treatments and expected symptoms, patients are often left with more questions than answers. As a cancer survivor, who is grateful to have a healthy and full life ahead of me, I hope that my experience and this legislation will help others better navigate a diagnosis. I am grateful for the support of my co-chair Congressman Carter on this effort,” said Congressman Mark DeSaulnier.

“As a pharmacist for more than 30 years, I have cared for many cancer patients and survivors and I also have personal experience dealing with my father’s battles with cancer,” said Congressman Carter. “I’ve seen firsthand that cancer patients should be focused on getting better instead of trying to navigate the complexities of their diagnosis without clear direction or knowing what to expect from their care, especially as cancer treatment choices become more advanced. I’m proud to introduce this legislation with my friend Congressman DeSaulnier to help provide a personalized written roadmap for patients as they fight against cancer through diagnosis, treatment and survivorship care.”

“We commend the Congressional Cancer Survivors’ Caucus co-chairs for advancing this important legislation,” said Louis M. Weiner, MD, director of Georgetown Lombardi Comprehensive Cancer Center. “It’s thrilling to be part of a new revolution of how we treat cancer using immunotherapies and many other transformative approaches to cancer therapy. We believe in research-inspired cancer care, and cancer care planning and communication is an integral part of ensuring that patients receive the right treatment at the right time. That’s what the Cancer Care Planning and Communications Act promotes.”

“Cancer survivors need all the support they can get, both during the early stages of diagnosis and treatment, but maybe, more importantly, once it is initially over. All levels of support can be greatly enhanced with a cancer care plan,” said Susan Leigh, a four-time cancer survivor and retired oncology nurse. “By promoting more in-depth discussions between providers and the families they care for, these plans act as roadmaps to identify risks, coordinate care, and reduce fears after treatment ends.”

Organizations supporting the CCPCA:

American Cancer Society Cancer Action Network (ACS CAN)
American Society for Radiation Oncology (ASTRO)
Association of Community Cancer Centers (ACCC)
CancerCare
Cancer Legal Resource Center
Children’s Cause for Cancer Advocacy (CCCA)
Colorectal Cancer Alliance
Georgetown Lombardi Comprehensive Cancer Center
Lacuna Loft
Laura and Isaac Perlmutter Cancer Center at NYU Langone
Leukemia & Lymphoma Society
LUNGevity Foundation
Lymphoma Research Foundation
Memorial Sloan-Kettering Cancer Center
National Coalition for Cancer Survivorship (NCCS)
National Patient Advocate Foundation
Susan G. Komen
Triage Cancer
University of Virginia Cancer Center
ZERO – The End of Prostate Cancer

Read additional information about the CCPCA »

# # #

Health Care Roundup: Medicaid Work Requirement Studies; Care Coordination/Planning; Financial & Emotional Distress; Cancer in Firefighters; More

17 Patient Groups Urge Appeals Court to Uphold Health Care Law

Health Care Roundup: Medicaid Work Requirement Studies; Care Coordination/Planning; Financial & Emotional Distress; Cancer in Firefighters; More

June 21, 2019/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Care Planning, Drug Pricing, Health Care Coverage, Quality Cancer Care, Shared Decision-Making Health Care Roundup, NCCS News /by actualize

Subscribe to our email list and receive these updates in your email box each week »

HEALTH CARE HIGHLIGHTS

New ACA Replacement Plan?

This week, President Trump hinted at his intention to introduce a new health care plan. Health care remains a very popular political issue among most voters. With widespread reports saying that many Republicans in Congress would rather not make health care or Affordable Care Act (ACA) replacement a top issue in the upcoming elections, it will be interesting to see whether the president follows through in the months ahead.

Direct-to-Consumer (DTC) TV Advertising Rule

In December, we shared information about a new rule from the Department of Health and Human Services requiring drug companies to post drug prices in television commercials. Experts have said that it’s unclear whether price transparency will have an effect on prices. Last week, several companies, including Amgen Inc., Merck & Co. Inc. and Eli Lilly and Co., and the Association of National Advertisers, file suit to block the rule. Amgen highlighted concerns regarding freedom of speech, and that the rule “may mislead patients and fails to take into consideration ‘differences among insurance, treatments, and patients themselves.’” (Stat News)

Medicaid Work Requirements

Two studies shed light on the new Medicaid work requirements. Researchers from the Harvard Chan School of Public Health reported on the initial results of Arkansas’ work requirements, the first implemented in the country. They found a significant loss in coverage, an increase in the uninsured rate, with no corresponding increase in employment rates.

“The idea of work requirements is to get people into new jobs and private insurance. But in our study that didn’t happen. We didn’t find any employment changes and instead we see Medicaid coverage rates dropping and more people without health insurance–usually because the process itself was confusing or beneficiaries didn’t even know about the new requirements,” said Benjamin Sommers, lead author of the study.

Additionally, the Commonwealth Fund reported that between 600,000 and 800,000 people could lose Medicaid coverage in nine states if proposed work requirements are fully implemented.

“Even if some people who lose coverage are able to reenroll later, coverage gaps will grow, potentially affecting health. This churning also drives up costs through higher administrative expenses and the greater costs of deferred care. The loss of Medicaid coverage also will shrink funding for health care, creating losses for safety-net hospitals and community health centers,“ wrote Leighton Ku and Erin Brantley.

2019 Scorecard on State Health System Performance

Commonwealth Fund

While former House Speaker Tip O’Neill is credited for saying “all politics is local,” a similar phrase could be made for health care. The quality and affordability of health care is increasingly being determined by where someone lives.

This analysis from the Commonwealth Fund used “recently available data to assess every state and Washington, DC on more than 40 measures of health care access, quality, efficiency, health outcomes and disparities,” and developed trends to see how your state improved or declined. See the interactive chart »

Support NCCS while shopping on Amazon. A portion of your Amazon purchases will be donated to NCCS when you choose NCCS as your AmazonSmile charity. Get started »

IMPORTANT READS

Cancer Survivors Deserve Coordinated Care

Scientific American

NCCS is a long-time proponent of coordinated care, since far too many patients and survivors today bear almost all responsibility to coordinate and advocate for the care they need. This article provides an excellent overview of the needs and challenges to make care coordination more universal.

Financial Hardship, Psychological Distress Hurting Working-Age Cancer Survivors, CDC Says

AJMC

A new report from the Centers for Disease Control and Prevention (CDC) sheds more light on the impact of cancer on working adults.

“More than a quarter of adults aged 18 to 64 years reported they had trouble paying bills because of cancer, and over one-third reported psychological distress, according to a report from the CDC.”

The report points out that since the number of Americans with a history of cancer are is expected to rise, these type of numbers will likely increase as well in the years to come.

Firefighters battle occupational cancer

CBS News

This CBS Sunday Morning News story looks at the troubling number of firefighters being diagnosed with cancer. “Since 2002, almost two out of every three firefighters who died in the line of duty died of cancer, according to the International Association of Fire Fighters.”

One theory for the cause is the types of toxins firefighters encounter due to changes in modern building materials. The article also points out the struggles many firefighters face to have their cancer care covered by workers compensation benefits.

Cancer survivorship plans mean an even better quality of life for patients

WKRC Columbus

A local news story in Ohio highlights another one of NCCS’ long-time priorities—cancer survivorship care plans. This is a great introduction to care plans which, when implemented correctly, can be an important resource for patients and their families to help with the transition from treatment to survivorship.

Cancer Survivors Predicted to Top 22 Million by 2030

WebMD

That’s the latest estimate in a new report from the American Cancer Society. Co-author of the report, K. Robin Yabroff, PhD, senior scientific director of health services research at ACS, said:

"People with a history of cancer have unique medical, psychosocial and economic needs that require proactive assessment and management by health care providers."

Dr. Yabroff shared more of her research on the costs and access to care in her presentation at NCCS’ Spring 2019 Cancer Policy Roundtable.

Health Care Roundup: ACA Erased Key Racial Cancer Disparity; ‘Survivor’ Debate; Isolation in Survivorship; Remembering Two Cancer Pioneers; More

NCCS “Not Persuaded” Drug Pricing in DTC Ads Will Improve Doctor-Patient Communication

Health Care Roundup: White House Proposes Health Care Cuts; NCI’s Sharpless to Head FDA; Care Planning; Patient Safety; More

March 15, 2019/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Care Planning, Health Care Coverage, Quality Cancer Care Health Care Roundup, NCCS News /by actualize

In order to bring you the latest cancer-related health care policy and news, we at NCCS combined our ACA Updates and What Caught Our Eye (WCOE) content into a weekly email and blog post. We aim to make the Health Care Roundup a concise, one-stop summary of what you need to know as we continue working together to make cancer care better for everyone.Your feedback is always welcome to make our content more useful to you. Please send comments to feedback@canceradvocacy.org.

Subscribe to our email list and receive these updates in your email box each week »

HEALTH CARE HIGHLIGHTS

White House Releases FY 2020 Budget

Earlier this week, the White House released the President’s Budget. This year's budget proposes to repeal and replace the Affordable Care Act (ACA) and cap Medicaid, and cuts federal health spending by $659 billion over 10 years. The budget also proposes shaving $818 billion from projected spending on Medicare over 10 years and cutting nearly $1.5 trillion from projected spending on Medicaid. In place of the current Medicaid structure, President Trump’s budget would give states “market-based health care grants” over 10 years. Congress rejected this idea in 2017 as part of the Graham-Cassidy bill because it would essentially cap Medicaid and would not keep pace with rising health care costs.

As the New York Times reports, the budget is seen by Democratic leaders as dead on arrival and is unlikely to have much effect on actual spending levels, which are controlled by Congress.

NCI's Sharpless Named FDA Acting Commissioner

This week, it was announced that Dr. Ned Sharpless of the National Cancer Institute (NCI) will become Acting Commissioner of the Food and Drug Administration (FDA) once Dr. Scott Gottlieb steps down. Dr. Sharpless has served as director of the NCI since 2017, and is also chief of the aging biology and cancer section in the National Institute on Aging’s Laboratory of Genetics and Genomics. His research focuses on the relationship between aging and cancer, and development of new treatments for melanoma, lung cancer and breast cancer.

NCCS is pleased to have Dr. Sharpless join us later this month at our biannual Cancer Policy Roundtable event to hear more about his focus areas and new role at the FDA.

CHART OF THE WEEK

The President’s Budget Request

Centers for Medicare and Medicaid Services (CMS)

This year's budget proposes to repeal and replace the ACA and cap Medicaid, and cuts federal health spending by $659 billion over 10 years, as seen in the chart below:

Support NCCS while shopping on Amazon. A portion of your Amazon purchases will be donated to NCCS when you choose NCCS as your AmazonSmile charity. Get started »

IMPORTANT READS

Survivorship Care Plans May Help Patients After Cancer Treatment

Oncology Nursing News

Deborah A. Boyle, MSN, RN, AOCNS, FAAN, editor in chief of Oncology Nursing News, talks about the importance of survivorship care planning. She admits that while there’s still debate concerning care plans, “there needs to be a communication tool for all stakeholders involved with cancer survivorship.”

Few Physicians Using CMS Advance Care Planning Codes

Medscape – (Free registration required to view article)

NCCS is a long-time proponent of advance care planning and palliative care. This article outlines how many physicians are not using advance care planning codes for Medicare beneficiaries, saying:

“The authors conclude that either clinicians are not having conversations with patients about their values and their life goals regarding their future healthcare, or they are having the conversations but are not billing properly or consistently for them.”

2019 Top 10 List of Patient Safety Concerns

Medscape – (Free registration required to view article)

The non-profit ECRI Institute recently released it’s “2019 Top 10 Patient Safety Concerns” report. “This was the second year in a row that diagnostic errors were flagged as the most serious safety challenge in ECRI's annual compendium.” The implications for the millions of cancer patients diagnosed each year, and the millions more in survivorship, are obvious.

State of Cancer Care in America (SOCCA): Reflections on an Inaugural Year

Journal of Oncology Practice

This editorial, published in the American Society of Clinical Oncology’s journal as part of their "SOCCA" series of articles, provides an oncologist perspective of cancer care in America.

The authors point out:

“The overarching message from this year’s SOCCA series is that cancer care teams are practicing in a complex health care delivery system. This complexity is driven by (1) reimbursement and financial challenges, (2) limitations of electronic health record (EHR) systems, and (3) the organization and geographic distribution of the workforce.”

Health Care Roundup: FDA’s Gottlieb Steps Down; Hearings on High Costs; Coping with Cancer’s Aftermath; Why Insurers Deny Claims; More

Health Care Roundup: Senate Hearing w/Pharma CEOs; Medicare for All Introduced; Logistical Toxicity; FDA Warns About Robotic Surgical Devices; More

Health Care Roundup: New Health Care Bills; NCCS Co-Founder Susie Leigh on Life After Cancer; Oncology Care Model; Racial Disparities; More

February 15, 2019/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Care Planning, Drug Pricing, Financial Toxicity, Health Care Coverage, Health Equity, Quality Cancer Care Health Care Roundup, NCCS News /by actualize

In order to bring you the latest cancer-related health care policy and news, we at NCCS combined our ACA Updates and What Caught Our Eye (WCOE) content into a weekly email and blog post. We aim to make this a concise, one-stop summary of what you need to know as we continue working together to make cancer care better for everyone.Your feedback is always welcome to make our content more useful to you. Please send comments to feedback@canceradvocacy.org.

Subscribe to our email list and receive these updates in your email box each week »

HEALTH CARE HIGHLIGHTS

Health Care Bills Discussed, ACA Lawsuit News

A group of Democratic lawmakers this week introduced legislation that would allow for a “Medicare Buy-In,” meaning Americans at age 50 could buy into the program for their health care coverage. Spearheaded by Sen. Debbie Stabenow (MI-D) and Rep. Brian Higgins (NY-26), the legislators say the main goal is to promote more affordable coverage.

Hearings on the ACA and drug pricing continued this week, as the House Energy and Commerce Committee held a hearing titled, “Strengthening Our Health Care System: Legislation to Reverse ACA Sabotage and Ensure Pre-existing Conditions Protections.” The hearing was centered around a series of bills that would address actions by the Trump administration to weaken the ACA’s markets and patient protections.

An important update in the Texas v. United States ACA lawsuit was announced on Valentine’s Day. Four additional states—Colorado, Iowa, Michigan, and Nevada—were granted their request to intervene in the lawsuit. The Fifth Circuit also denied a request for an expedited schedule. NCCS will continue to monitor and report on this important case.

CHART OF THE WEEK

The Out-of-Pocket Cost Burden for Specialty Drugs in Medicare Part D in 2019

Kaiser Family Foundation

While Congress takes a closer look at rising drug costs and considers options to reduce drug prices, the administration is releasing policy proposals that seek to do the same. One thing is certain: Out-of-pocket spending for prescription drugs, especially for cancer, are enormous.

Chart and Data Source: Kaiser Family Foundation

Support NCCS while shopping on Amazon. A portion of your Amazon purchases will be donated to NCCS when you choose NCCS as your AmazonSmile charity. Get started »

IMPORTANT READS

Life after cancer: More survivors living longer, facing new health challenges

USA Today

In this USA Today feature, NCCS co-founder Susie Leigh shares her experience with being diagnosed with cancer at 24. Since that diagnosis, she’s had breast, bladder and lung cancer, and developed congestive heart failure. Susie discusses how this impacted her life, the founding of the National Coalition for Cancer Survivorship, and the importance of furthering the understanding of survivorship issues throughout the cancer community.

What Is The Oncology Care Model, And Why Is The Evaluation Important?

Health Affairs

You may or may not have already heard of the Oncology Care Model (OCM). Either way, there’s a good chance it could become the future of how cancer care is delivered and important to understand the basics of the program. Organized by the Center for Medicare and Medicaid Innovation (CMMI), the goal is to “improve care coordination, appropriateness, and access for beneficiaries undergoing chemotherapy, while reducing total costs.”

This article is a good summary of what the OCM is, what it hopes to achieve, where it excels, and some of its shortcomings.

Opinion: How to fight the financial toxicity of cancer treatment

MarketWatch

We all understand the devastating financial impact a cancer diagnosis has on patients and their families. Recently referred to as financial toxicity, this article discusses it in-depth and offers some advice for patients and providers to help reduce this burden.

Racial Disparities in Cancer are Narrowing

National Public Radio (NPR)

A recent analysis by the American Cancer Society found that the gap in racial disparities in cancer are narrowing, with four major cancers declining more among blacks than among whites. Still, African-Americans bear a disproportionate share of the cancer burden in the U.S. and experience the lowest survival rates of any racial or ethnic group.

Health Care Roundup: Drug Pricing; Cancer Deaths Rise Globally; Health Care Champion John Dingell Remembered; Treatment at Home; “Survivor” Debate

Health Care Roundup: More Drug Pricing News; Clinical Trial Challenges; Trump Promises Action on Surprise Billing; Fake Cancer Cures; More

What Caught Our Eye: ACA Auto-Enrollment; Lack of Care Plan Implementation; Second Opinions; ‘Cancer’s New Superheroes’; More

May 4, 2018/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Care Planning, Clinical Trials, Financial Toxicity, Health Care Coverage, Health Equity, Quality Cancer Care, Survivorship Care NCCS News /by actualize

What Caught Our Eye (WCOE), May 4, 2018
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

Affordable Care Act

“Making Heath Insurance Enrollment As Automatic As Possible”

I was pleased to join with bipartisan co-authors @standorn @FamiliesUSA and Jim Capretta @AEI to describe @Health_Affairs Blog how we can make health insurance more affordable and accessible: https://t.co/GjGQv0ylGz

— Lanhee J. Chen (@lanheechen) May 2, 2018

Via Health Affairs Blog — In December 2017, the Republican Congress, working with the Trump administration, repealed the tax penalties enforcing the Affordable Care Act’s (ACA) individual mandate, effective in 2019. Although the degree of the mandate’s efficacy is uncertain, its repeal is sure to lead to additional Americans going without coverage, exacerbating the instability that now affects the individual insurance markets of many states.

In this context, it is incumbent on federal and state policymakers to enact replacement policies for the ACA’s individual mandate. More fundamentally, the individual market’s core dysfunction remains in place: Many young and healthy consumers remain outside the market, increasing average risk levels and premiums, and leaving millions of people needlessly uninsured. Those enrollment choices involve the perception and the reality of unaffordable coverage, but they also reflect burdens of enrollment and plan selection that have an outsize impact on program participation.
Read More »

Cancer Policy

“The Forgotten Piece of Continuum of Care”

Years after their implementation, survivorship care plans are often an afterthought: https://t.co/WNq0FfHYbj #cancertreatment #cancersurvivors

— CURE Magazine (@cure_magazine) May 2, 2018

Via CURE Magazine — In 2005, the National Research Council and Institutes of Medicine published “From Cancer Patient to Cancer Survivor: Lost in Transition,” the first comprehensive document on cancer survivorship, which included 10 recommendations. First, it called for health care providers and patient advocates to recognize survivorship as its own, distinct phase of cancer care. The second recommendation advised that a survivorship care plan (SCP) be provided for all patients.
Read More »

“CDC Eyes Review of Gynecological Cancer Screens”

@CDCgov plans to review whether gynecologists should do more cancer screening before hysterectomies and other common procedures, according to sources. W/@jenniferlevitz. https://t.co/Q2AYr0s0E1

— Betsy McKay (@betswrites) May 3, 2018

Via Wall Street Journal — The Centers for Disease Control and Prevention plans to review whether gynecologists should conduct more cancer screening before common procedures such as hysterectomies, according to people familiar with the agency’s plans.
Read More »

“Paying For Value: Lessons From The Medicare Hospice Benefit”

In today's @Health_Affairs blog @JoanMTeno makes a very good point that the #Medicare #Hospice benefit design was optimized for an old cancer framework and the subsequent updates are tweaks to the same chassishttps://t.co/PVvokwHK7c

— David Anderson (@bjdickmayhew) May 2, 2018

Via Health Affairs Blog — The reimbursement system and the pathway of least resistance are aligned with “doing more” instead of focusing on in-depth conversations or formulating and executing plans of care that promote person- and family-centered care.
Read More »

Coping with Cancer

“Love Your Cancer Doctor? Get a Second Opinion”

Love Your Cancer Doctor? Get a Second Opinion https://t.co/9GuedSklKn

— NYTimes Well (@nytimeswell) May 2, 2018

Via New York Times Well Blog — You don’t think twice about getting multiple bids for a construction or plumbing project, so why hesitate on multiple “bids” for your health?

I learned the value of a second opinion a year and a half ago when two breast cancer surgeons presented me with very different treatment options.
Read More »

“The ‘Ross-Wonders’, Cancer’s New Superheroes”

This is such a great story. Well done! “In this case, it was the patients themselves who organized as a group” to launch a ROS1 study. “As far as I know it’s the first time that’s happened.” @GoldmanLisa @JFreemanDaily @lil_lytnin #lcsm #PrecisionMedicine https://t.co/JQNNeU1t8w

— Dave Bjork (@bjork5) May 3, 2018

Via Forbes — You’ve likely never heard the story of how three young women, who call themselves “ROS1ders” from a rare form of lung cancer they share, may be turning the nation’s 46-year-old war on cancer on its head. The women were diagnosed with a gene mutation called a ROS1 fusion. Less then 2 percent of lung cancer patients have that trait. They soon found out there was little research being conducted because of the difficulty in finding and collecting tissue samples. In other words they were stuck with existing treatments and a drug designed for other types of lung cancers. Their future did not look bright.
Read More »

“The Latest Look at FDA’s Breakthrough Designation Finds No Benefits from Cancer Meds”

STAT Plus: “The term breakthrough may also be used to justify exceptionally high prices.” https://t.co/i79FzhUvqx

— STAT (@statnews) May 2, 2018

Via STAT News — The idea of a breakthrough therapy was promoted to speed approvals of medicines that held promise for treating a life-threatening disease and demonstrated substantial improvement over existing drugs. However, a new study finds that while cancer drugs considered to be breakthroughs were approved more quickly, they were not safer, more novel, or more effective than drugs not given this designation.

The study examined 58 new cancer medicines that were approved by the Food and Drug Administration between 2012 and 2017. Of these, 25 — or 43 percent — received breakthrough therapy designation. The median time to a first FDA approval was 5.2 years for drugs that given a breakthrough designation versus 7.1 years for cancer medicines that were not considered to be breakthroughs.
Read More »

“Corners of the Immunotherapy Space are Getting Crowded. Is that a Problem?”

Five approved checkpoint-inhibitor drugs rev up the immune system to fight cancer. Forty-five similar ones are in clinical trials. https://t.co/ZeIGafFHjT

— STAT (@statnews) May 1, 2018

Via STAT News — There’s an overabundance of copycat drugs in the cancer immunotherapy space, with companies pouring millions into developing drugs that add only incremental value to patients.

That was the general consensus from a panel of biotech experts who spoke here Monday at the Milken Institute Global Conference — a commingling of Wall Street titans, policy wonks, industry leaders, and Hollywood elites. While excitement around harnessing the immune system to attack cancer is justifiable, they said, the way in which company resources are allocated in the immunotherapy space is skewed.

“The immuno-oncology field is too crowded,” said Pablo Legorreta, CEO of Royalty Pharma, a New York-based venture capital firm. “We don’t need 30 similar drugs, because a lot of them will become me-too drugs. And that’s not OK for patients.”
Read More »

More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy

Reps. DeSaulnier and Poe Introduce Bipartisan “Cancer Care Planning and Communications Act”

March 8, 2018/in Cancer News, Cancer Policy Blog, NCCS News Access to Care, Care Planning, Clinical Guidelines, Health Care Coverage, Quality Cancer Care, Shared Decision-Making NCCS News /by actualize

Advocated for by NCCS, the bill would increase comprehensive cancer care planning for millions of Medicare beneficiaries.

Washington, D.C. – Today, Rep. Mark DeSaulnier (D-CA) and Rep. Ted Poe (R-TX), both cancer survivors and co-chairs of the Congressional Cancer Survivors Caucus, introduced H.R. 5160, the Cancer Care Planning and Communications (CCPC) Act.

A longtime legislative priority of the National Coalition for Cancer Survivorship, the bill would create a Medicare code to reimburse providers for time and resources used to create cancer care plans for Medicare beneficiaries.

“The Cancer Care Planning and Communications Act is a tangible way to significantly improve the quality of care for cancer patients in Medicare,” said NCCS CEO Shelley Fuld Nasso. “Care plans before, during, and after treatment encourage communication between providers and patients, and help alleviate some anxiety at every phase of the care continuum. The CCPC Act would empower patients with tools to manage and coordinate their care from active treatment throughout survivorship. NCCS and our partners look forward to working with Reps. DeSaulnier and Poe to move the CCPC Act forward.”

“Cancer is an epidemic in our country. Approximately 1.7 million Americans will be diagnosed with cancer this year alone. As a cancer survivor myself, I know how difficult it can be to understand what the plan for a patients’ treatment is,” said Congressman Ted Poe. “This legislation takes a positive step forward by incentivizing doctors to help their patients understand their planned cancer care path and giving them the peace of mind, all cancer patients, and their families deserve.”

“As a cancer survivor, I know firsthand how important having a care plan is to receiving the best care possible,” said Lee Jones, a cancer survivor. “A care plan is not only critical to fostering communication between a patient and doctor, but it serves as a roadmap in helping navigate the difficult process of cancer diagnosis, treatment choices, and treatment management. This is particularly true for older survivors on Medicare, who also are dealing with risk of recurrence, secondary cancers and other health issues. I am proud to support the passage of the Cancer Care Planning and Communications Act, and hope it is quickly passed by Congress to help make sure all patients receive the best care possible.”

“We commend the Congressional Cancer Survivors co-chairs for advancing this important legislation,” said Donald L. Trump, MD, FACP, CEO and Executive Director of the Inova Schar Cancer Institute. “The data show clearly that personalized and coordinated care leads to better outcomes—including longer survival! Based on these data, our center is designed as a facility where patients will have a single location to see their interdisciplinary team—medical , surgical and radiation oncologists, nutritionist, genetic and psychosocial counselors, all collaborating on a personalized plan for each patient, a treatment plan specific to the genomics and proteomics of their tumor, specific to their pharmacogenomics as appropriate and a survivorship plan to maximize the chance for survival and good health following treatment. Cancer care is more and more complicated—and successful; it is critical that physicians and patients be full partners in their treatment, that the overall plan of treatment and post-treatment care be fully developed and communicated—that’s what the Cancer Care Planning and Communications Act is promoting.”

Patient and professional organizations supporting the CCPC Act:

American College of Surgeons Commission on Cancer; American Society of Clinical Oncology; Association of Community Cancer Centers; Association of Oncology Social Work; Cancer Legal Resource Center; Cancer Support Community; College of American Pathologists; Colon Cancer Alliance; Critical Mass; Fight Colorectal Cancer; Hematology Oncology Pharmacy Association; International Myeloma Foundation; Lacuna Loft; LIVESTRONG; Lung Cancer Alliance; LUNGevity Foundation; Lymphoma Research Foundation; National Brain Tumor Society; National Patient Advocate Foundation; Oncology Nursing Society; Pancreatic Cancer Action Network; Stupid Cancer; The Children’s Cause for Cancer Advocacy; The Leukemia & Lymphoma Society; Triage Cancer; West Virginia Oncology Society; Zero Prostate Cancer.

Cancer centers supporting the CCPC Act:

City of Hope National Medical Center; Dana-Farber Cancer Institute; Georgetown Lombardi Comprehensive Cancer Center; Laura and Isaac Perlmutter Cancer Center at NYU Langone;
Loma Linda University Cancer Center; Masonic Cancer Center; Memorial Sloan-Kettering Cancer Center; Moffitt Cancer Center; Norris Cotton Cancer Center; Rutgers Cancer Institute
Stanford Cancer Institute; The University of Kansas Cancer Center; The University of Kentucky Markey Cancer Center; The University of Texas MD Anderson Cancer Center; The University of Virginia Cancer Center; UC Davis Comprehensive Cancer Center.

# # #

Find more CCPC Act information and advocacy tools for contacting Congress ».

What Caught Our Eye: NCI Chief Sharpless Interviewed; Expert Patients; “Why We Didn’t Seek Right to Try”; Progress in Survivorship Care; and More

March 2, 2018/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Care Planning, Clinical Trials, Quality Cancer Care, Shared Decision-Making NCCS News /by actualize

What Caught Our Eye (WCOE), March 2, 2018
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

Health Insurance

“Bait And Switch: The Sneaky Way Your Employer Just Passed Healthcare Costs Onto You”

More Americans are now on high out-of-pocket health insurance plans through their employers. The premiums may be cheaper, but these plans are not always great bargains for workers. @forbeshealth https://t.co/3aJYPHOXVy pic.twitter.com/mX1TeM23Ul

— Peter Ubel (@peterubel) March 2, 2018

By Peter Ubel, Forbes.com — With increasing frequency, employers are directing their workers to the kind of high deductible, high out-of-pocket insurance plans that leave workers financially responsible for a surprising portion of their healthcare expenses.
Read More »

“Congress Races The Clock In Quest To Bring Stability To Individual Insurance Market”

tick tick tick. Congress's window for stabilizing individual insurance markets is closing fast. my latest:https://t.co/Hsja5rRu7V

— julie rovner (@jrovner) March 2, 2018

By Julie Rovner, Kaiser Health News — Congress is running out of time if members want to come up with legislation to stabilize the individual insurance market. While Republicans and Democrats still feud over the fate of the Affordable Care Act, a bipartisan group of senators and House members has been working since last summer on measures to keep prices from rising out of control and undermining the individual market where people who don’t get insurance through work or the government buy policies.
Read More »

Cancer Policy

“His six-month “listening tour” almost over, Sharpless discusses his vision for NCI”

His six-month “listening tour” almost over, Sharpless discusses his vision for NCI (https://t.co/JfGyWlwTlw) pic.twitter.com/XeIV6nltVd

— The Cancer Letter (@TheCancerLetter) February 26, 2018

By Paul Goldberg, The Cancer Letter — “The notion that cancer’s not one disease, but thousands of diseases is really starting to sink in, and the implications of that fact are being felt throughout [NCI], and it means we have to change how we do everything. I hope that the early days of the Sharpless administration will be remembered as a time when we really bought into that reality and did some things differently,” NCI Director Norman “Ned” Sharpless said in a conversation with The Cancer Letter.
Read More »

“I have brain cancer. Drug companies and med schools should be compensating me for my expertise”

I’ve learned that my knowledge is extremely valuable. I’ve also learned that it is undervalued.https://t.co/FAnLNzbA0G pic.twitter.com/H0TfgMBtcm

— STAT (@statnews) February 27, 2018

By Adam Hayden, STAT News — Expert patients offer value when it comes to medical education or the development of medical devices and drugs. It’s time for them to get the compensation they deserve for improving the health care experience for everyone.
Read More »

“A 25-Year Experience of US Food and Drug Administration Accelerated Approval of Malignant Hematology and Oncology Drugs and Biologics”

Nice FDA study of all 93 heme-onc indications approved via accelerated pathway as of 5/17; 55% fulfilled PMRs, verifying benefit 3.5 yrs (on avg) after approval, but 40% yet to complete confirmatory trial(s) or verified benefit, 5% withdrawn from market https://t.co/7dDHzVcQN4

— Joseph Ross (@jsross119) March 2, 2018

Scientific Review Published in JAMA Oncology — Accelerated approval (AA) is a US Food and Drug Administration (FDA) expedited program intended to speed the approval of drugs and biologics that may demonstrate a meaningful advantage over available therapies for diseases that are serious or life-threatening.
Read More »

Coping with Cancer

“My Mom Just Died From Cancer. Here’s Why We Didn’t Seek #RightToTry”

My Mom had 30 years of good living due to drugs developed in the 70s War on Cancer. But when her silent breast cancer reappeared in her bones in 2014, she kept the faith, staying with treatments that had passed the muster of clinical trials. https://t.co/n0GNlAM9IM #RightToTry

— David Kroll (@davidkroll) March 1, 2018

By Dave Kroll, Forbes.com — Few events are more jarring to the human experience than being diagnosed with an acutely life-threatening illness. Perhaps as devastating – or even worse – is when that person is a loved one, especially a child or a young life-partner.

And if you’re a young person, having a parent or close relative diagnosed with a terminal illness may be the most emotionally devastating experience you’ve faced to date.
Read More »

“Patricia A. Ganz, MD, on Progress in Cancer Survivorship Care”

Via ASCO Post — Patricia A. Ganz, MD, of the University of California, Los Angeles, and this year’s recipient of the Ellen Stovall Award for Advancement of Cancer Survivorship Care, discusses her 30-year-long career researching and advocating for survivors and quality care.
Read the post on ASCOpost.com »

More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy

What Caught Our Eye: Medicaid Coverage Limits; Cancer Care Cost Communication; Stanford Care Planning Study; Drug Pricing; and More

February 9, 2018/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Care Planning, Drug Pricing, Financial Toxicity, Health Care Coverage, Health Equity, Quality Cancer Care NCCS News /by actualize

What Caught Our Eye (WCOE), February 9, 2018
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

Affordable Care Act

“After Approving Medicaid Work Requirements, Trump HHS Aims for Lifetime Coverage Limits”

.@HHSgov considering lifetime limits on #Medicaid coverage is very concerning. Would be devastating for #Cancer patients as many would be among first to hit limits due to high cost of cancer care, including those patients depending on Medicaid for their long-term follow-up care. https://t.co/DA6hBZ6pDs

— NCCS – National Coalition for Cancer Survivorship (@CancerAdvocacy) February 6, 2018

BREAKING: This would be the wrong direction for our country and millions of Americans.

https://t.co/jqeS9JNpUW

— Andy Slavitt @ 🏡 (@ASlavitt) February 6, 2018

By Tony Pugh, McClatchy News — After allowing states to impose work requirements for Medicaid enrollees, the trump administration is now pondering lifetime limits on adults’ access to coverage.

Capping health care benefits — like federal welfare benefits — would be a first for Medicaid, the joint state-and-federal health plan for low-income and disabled Americans.
Read More »

“Despite Changes That Undermined ACA Enrollment, Marketplaces ‘Remarkably Stable’”

Marketplace directors release report showing a mixed bag on ACA enrollment — and warn of sharp price hikes for 2019 if nothing is done. https://t.co/nYfplpxaZ9

— Julie Appleby (@Julie_appleby) February 8, 2018

By Julie Appleby, Kaiser Health News — After much drama leading to this year’s open enrollment for Affordable Care Act coverage — a shorter time frame, a sharply reduced federal budget for marketing and assistance, and confusion resulting from months of repeal-and-replace debate — the final tally paints a mixed picture.
Read More »

“Bipartisan Senate Budget Deal Boosts Health Programs”

next #WTHealth podcast coming tomorrow (waiting for outcome of budget fight). But meanwhile here's my and @shefalil's take on health items in the deal: https://t.co/jxqvIJ7f5G

— julie rovner (@jrovner) February 8, 2018

By Julie Rovner, NPR — In a rare show of bipartisanship for the mostly polarized 115th Congress, Republican and Democratic Senate leaders announced a two-year budget deal that would increase federal spending for defense as well as key domestic priorities, including many health programs.
Read More »

Coping With Cancer

“Talking to Doctors about your Bucket List Could Help Advance Care Planning”

VJ Periyakoil (@palliator), lead author of a new study that found 91% of 3,056 U.S. participants surveyed had made a bucket list, discusses how bucket lists can aid talks about life goals, health and advance care planning: https://t.co/vFdktPV4DZ pic.twitter.com/PgySgT4FgE

— Stanford Medicine (@StanfordMed) February 8, 2018

Stanford Medicine News — A Stanford study has found that a majority of people make bucket lists and suggests they can be useful in doctor-patient discussions about care plans.
Read More »

Cancer and Health Care Costs

“Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care”

Price Transparency for Whom? In search of out-of-pocket cost estimates to facilitate cost communication in cancer care

Our editorial with Tina Shih and @sfuldnasso #financialtoxicity https://t.co/BWLTzbfVaK @DukeCancer @MDAndersonNews @dukemargolis @CancerAdvocacy

— Yousuf Zafar, MD MHS (@yzafar) February 6, 2018

By Ya-Chen Tina Shih, Shelley Fuld Nasso, and S. Yousuf Zafar, PharmacoEconomics — High costs of cancer drugs have repeatedly provoked a public outcry over affordability of cancer care in news media and journal articles. Especially for patients diagnosed with cancer in the United States, the sustained increase in the cost of cancer care is believe to cause tremendous distress for patients and their families to the extent that the term ‘financial toxicity’ has been used to describe patients’ cost-related experiences, and coping strategies are being discussed.
Read More »

“Association of Patient Out-of-Pocket Costs with Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents”

Important study in @JCO_ASCO: The more #cancer patients pay for oral chemo, the more likely they are to stop taking those drugs. Why?:

1) high drug prices
2) more cost-sharing
3) clinicians not talking costs w/ptshttps://t.co/Z8IEONqZpm #financialtoxicity @CostsofCare pic.twitter.com/1K9JDLdL3z

— Yousuf Zafar, MD MHS (@yzafar) February 8, 2018

ASCO’s Journal of Clinical Oncology — The number of novel oral anticancer agents is increasing, but financial barriers may limit access. We examined associations between out-of-pocket (OOP) costs and reduced and/or delayed treatment initiation.
Read More »

“Is Federal Policy Really To Blame For The High Cost of Cancer Care?”

Research on hospital mergers & cancer drug pricing shows how “difference-in-difference” analyses can help sort out "cause-and-effect." The finding serves as a reminder to be careful about leaping from a time trend to a cause-and-effect explanation. https://t.co/18EwG9kVYe pic.twitter.com/bwBJ4hHm96

— Peter Ubel (@peterubel) February 8, 2018

By Peter Ubel, Forbes.com — U.S. healthcare costs have been high for decades, outpacing other developed countries since at least the 1980s. But costs continue to rise, and that is causing many experts to ask why. Some people blame federal policies. As an example, they point to reimbursement policies that create incentives for healthcare providers to consolidate. When hospitals merge with each other, or when hospitals buy out physician practices, healthcare providers gain negotiating leverage over insurers, which enables them to negotiate higher prices.
Read More »

“Drugs Don’t Work If People Can’t Afford Them: The High Price of Tisagenlecleucel”

Drugs don’t work if people can’t afford them. Americans deserve transparency in pricing decisions for durigs invented using taxpayer funding. @P4AD_ @PORTAL_Research https://t.co/m9vgX12tTF

— Health Affairs (@Health_Affairs) February 8, 2018

Via Health Affairs Blog — In a system in which life-saving drugs are developed with direct and indirect taxpayer support and afforded market protection through government-granted exclusivities, patients deserve to know how drug manufacturers are arriving at ever-higher prices for their products. Without such information—and subsequent policy reforms based on it—treatment will become increasingly unaffordable. Sadly, for many Americans, it already has; 21 percent of 1,204 respondents in a December 2016 Henry J. Kaiser Family Foundation survey reported that they or a family member did not fill a prescription in the past year because of cost.
Read More »

More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy

Posts

Some of the key findings include:

Treatment Experiences

Post-Treatment Information and Care

Survivorship Needs

ACCC and NCCS Joint Survey Report

Read the Final Survey Report

HEALTH CARE HIGHLIGHTS

Cancer Care Planning and Communications Act Introduced in the House

Drug Importation Plan Announced

Senate Drug Pricing Package

CHART OF THE WEEK

IMPORTANT READS

Related Posts

Championed by NCCS, the bill would increase comprehensive cancer care planning for millions of Medicare beneficiaries.

Organizations supporting the CCPCA:

Related Posts

HEALTH CARE HIGHLIGHTS

New ACA Replacement Plan?

Direct-to-Consumer (DTC) TV Advertising Rule

Medicaid Work Requirements

IMPORTANT READS

Related Posts

HEALTH CARE HIGHLIGHTS

White House Releases FY 2020 Budget

NCI's Sharpless Named FDA Acting Commissioner

CHART OF THE WEEK

IMPORTANT READS

Related Posts

HEALTH CARE HIGHLIGHTS

Health Care Bills Discussed, ACA Lawsuit News

CHART OF THE WEEK

IMPORTANT READS

Related Posts

Affordable Care Act

Cancer Policy

Coping with Cancer

Patient and professional organizations supporting the CCPC Act:

Cancer centers supporting the CCPC Act:

Health Insurance

Cancer Policy

Coping with Cancer

Affordable Care Act

Coping With Cancer

Cancer and Health Care Costs

Take Action

Stovall Award

Join CPAT

Share Your Story

STAY CONNECTED